CLSD insider trading
NasdaqGM HealthcareClearside Biomedical, Inc.: insider trade history from SEC Form 4 filings.
About Clearside Biomedical, Inc.
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. On November 23, 2025, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Company website: clearsidebio.com
CLSD insider activity at a glance
FilingIQ tracks 193 insider transactions for CLSD in filings since Jun 7, 2016. The most recent transaction is dated Feb 24, 2025.
Across the full history, 46 open-market purchases
and 101 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest CLSD Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CLSD?
- FilingIQ tracks 193 Form 4 insider transactions for CLSD (Clearside Biomedical, Inc.), covering filings from Jun 7, 2016 onwards. 0 of those are dated within the last 90 days.
- Are CLSD insiders net buyers or net sellers?
- Across the full Form 4 history for CLSD, 46 transactions (24%) were open-market purchases and 101 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CLSD insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is CLSD in?
- Clearside Biomedical, Inc. (CLSD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.15M.
Methodology & sources
Every CLSD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.